Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when EZRA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsReliance Global expands equity plan 8x to 16M shares, approves Nasdaq dilution waiver
Filed May 7, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
high
Shareholders approved expanding the 2025 Equity Incentive Plan by 14 million shares (from 2M to 16M total), an 8x increase that significantly expands the compensation pool and potential dilution for existing holders.
Item 5.07: Annual Meeting Results verify on EDGAR → -
high
Approved share issuance exceeding Nasdaq's 20% Exchange Cap under a Common Stock Purchase Agreement from August 2025, allowing the company to issue additional shares beyond normal limits without further shareholder votes.
Item 5.07: Nasdaq Rule 5635(d) verify on EDGAR → -
low
Five directors elected to one-year terms through 2027: Ezra Beyman, Alex Blumenfrucht, Scott Korman, Ben Fruchtzweig, and Sheldon Brickman, all receiving majority support from voting shares.
Item 5.07: Director Elections verify on EDGAR → -
low
Shareholders ratified Urish Popeck & Co. as independent auditor for fiscal 2026 with 95% approval (9.2M votes for vs 105K against).
Item 5.07: Auditor Ratification verify on EDGAR →
Summary
Reliance Global held its annual shareholder meeting on May 6, 2026, where two significant dilution-related proposals passed despite notable opposition. The company expanded its equity compensation plan by 700%—adding 14 million shares to a pool that previously held just 2 million.
Separately, shareholders authorized the company to issue shares beyond Nasdaq's standard 20% limit under an existing purchase agreement, effectively waiving normal anti-dilution protections. Both proposals saw roughly 20-25% of voting shares cast against them, suggesting meaningful shareholder concern about dilution.
The equity plan expansion is particularly aggressive for a company of Reliance Global's size and could substantially dilute existing ownership if fully utilized for employee compensation or other purposes. Retail investors should monitor upcoming 10-Q and proxy filings to see how quickly the company draws on this expanded share pool, whether for executive compensation, employee retention, or capital raises. The August 2025 purchase agreement referenced in the Nasdaq approval may also warrant review to understand the specific dilution mechanics and pricing terms.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Annual shareholder meeting held May 6, 2026: five directors elected, auditor ratified, equity plan expanded by 14M shares, Nasdaq share issuance approved.
Added in current filing · verify on EDGAR →
The amendment to the Company’s 2025 Equity Incentive Plan, to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares, from 2,000,000 shares to 16,000,000 shares, was approved: Votes For | Votes Against | Votes Abstained | Broker Non-Votes | 2,780,312 | 789,931 | 119,036 | 5,902,355
Shareholders approved a significant expansion of the 2025 Equity Incentive Plan, increasing available shares by 14,000,000 (from 2,000,000 to 16,000,000 total shares). This represents an 8x increase in the equity compensation pool. The proposal passed with 2,780,312 votes for versus 789,931 against, indicating some shareholder concern about potential dilution.
Added in current filing · verify on EDGAR →
The issuance of shares of the Company’s common stock in excess of the Exchange Cap for purposes of Nasdaq Listing Rule 5635(d), pursuant to that certain Common Stock Purchase Agreement dated as of August 26, 2025, as amended, was approved: Votes For | Votes Against | Votes Abstained | Broker Non-Votes | 2,865,554 | 717,894 | 105,831 | 5,902,355
Shareholders approved the issuance of shares exceeding the Nasdaq Exchange Cap under Listing Rule 5635(d), related to a Common Stock Purchase Agreement dated August 26, 2025. This authorization allows the company to issue additional shares beyond the 20% threshold that typically requires shareholder approval under Nasdaq rules. The proposal passed with 2,865,554 votes for and 717,894 against.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The following five director nominees were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Nominee | Votes | For | Votes | Against | Votes | Abstained | Broker | Non-Votes Ezra Beyman | 3,409,300 | 0 | 279,979 | 5,902,355 Alex Blumenfrucht | 3,296,777 | 0 | 392,502 | 5,902,355 Scott Korman | 3,300,626 | 0 | 388,653 | 5,902,355 Ben Fruchtzweig | 3,275,234 | 0 | 414,045 | 5,902,355 Sheldon Brickman | 3,332,419 | 0 | 356,860 | 5,902,355
Five directors were elected at the 2026 Annual Meeting: Ezra Beyman, Alex Blumenfrucht, Scott Korman, Ben Fruchtzweig, and Sheldon Brickman. All five received majority support from voting shares, though a significant number of broker non-votes (5,902,355 shares) were recorded for each nominee. These directors will serve until the 2027 Annual Meeting.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify